Cargando…
Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
Alzheimer’s disease (AD) is a form of dementia and the most common progressive neurodegenerative disease (ND). The targeting of amyloid-beta (Aβ) aggregation is one of the most widely used strategies to manage AD, and efforts are being made globally to develop peptide-based compounds for the early d...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808296/ https://www.ncbi.nlm.nih.gov/pubmed/29467644 http://dx.doi.org/10.3389/fnagi.2018.00021 |